NDEA

Individuals and Entities who Consumed and/or Paid for Valsartan or Valsartan‐Containing Drugs, a Class Action Lawsuit Could Affect Your Rights

Retrieved on: 
Monday, December 4, 2023

The Court has not decided whether the Defendants did anything wrong or whether the Plaintiffs' claims have merit.

Key Points: 
  • The Court has not decided whether the Defendants did anything wrong or whether the Plaintiffs' claims have merit.
  • If you qualify as a member of a Class, you have the right to participate as a class member or to opt out.
  • You may visit the Case Website to register for case updates regarding the Lawsuit and any potential recovery or benefits to class members.
  • Opt-Out: All individuals and entities that satisfy a Class definition will be automatically included in the Class unless they choose to opt-out from the Class and Lawsuit entirely.

Slack Davis Sanger: Class-action lawsuits against generic Valsartan manufacturers moves forward

Retrieved on: 
Monday, February 13, 2023

Valsartan is a popular generic prescription medicine indicated to treat hypertension, and originally sold under the trade names of DIOVAN® and EXFORGE®.

Key Points: 
  • Valsartan is a popular generic prescription medicine indicated to treat hypertension, and originally sold under the trade names of DIOVAN® and EXFORGE®.
  • Since 1993, Slack Davis Sanger has been serving clients nationally and internationally with personal injury claims, wrongful death, and medical malpractice claims.
  • With a combined experience of more than 250 years, Slack Davis Sanger attorneys have extensive experience in litigation involving class action lawsuits and whistleblower cases.
  • For more information or to speak with John Davis, please contact Marketing Manager Stephanie Eitrheim at Slack Davis Sanger at 512-225-5322.